Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
AVEO PHARMACEUTICALS, INC. (AVEO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 11.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 88.8% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | 143.8% | 369.1% | 38.9% | 199.3% | | | | |
| Research and development | 62.2% | 376.8% | 62.4% | 381.8% | 332.2% | 942.5% | 67.7% | 211.1% |
| General and administrative | | | | | 120.6% | 326.2% | 53.7% | 102.6% |
| EBITDA | -117.5% | -726.9% | -41.5% | -481.1% | -380.1% | -1167.5% | 7.9% | -179.3% |
| Depreciation | 0.2% | 0.3% | | | | 1.2% | 50.3% | 34.3% |
| EBIT | -117.6% | -727.3% | -41.5% | -481.1% | -380.1% | -1168.7% | -42.4% | -213.7% |
| Pre-tax income | -126.1% | -591.2% | 32.6% | -98.5% | -856.6% | -1065.0% | -78.9% | -291.0% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 1.3% | 4.0% | 0.0% | 0.0% |
| Net income | -126.1% | -591.2% | 32.6% | -98.5% | -858.0% | -1069.1% | -78.9% | -291.0% |
|